Avalon Trust Co acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 79,712 shares of the conglomerate's stock, valued at approximately $15,184,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Pacific Sage Partners LLC acquired a new position in Danaher during the 2nd quarter worth approximately $316,000. TFR Capital LLC. acquired a new stake in Danaher in the second quarter valued at approximately $3,233,000. Family Legacy Inc. bought a new stake in shares of Danaher during the second quarter worth $1,150,000. Clearstead Trust LLC bought a new stake in shares of Danaher during the second quarter worth $720,000. Finally, Bridgewater Advisors Inc. acquired a new position in shares of Danaher during the second quarter worth $1,153,000. Institutional investors own 79.05% of the company's stock.
Analysts Set New Price Targets
DHR has been the subject of a number of research reports. Jefferies Financial Group reiterated a "buy" rating and issued a $245.00 price target on shares of Danaher in a research note on Tuesday, April 21st. Weiss Ratings raised Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, July 15th. Royal Bank Of Canada increased their target price on Danaher from $200.00 to $215.00 and gave the company an "outperform" rating in a research report on Wednesday, July 22nd. Wolfe Research lowered Danaher from an "outperform" rating to a "peer perform" rating in a research note on Monday, June 1st. Finally, Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They set a "buy" rating and a $230.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $228.91.
Read Our Latest Report on Danaher
Danaher Stock Performance
NYSE DHR opened at $202.51 on Friday. The company has a market capitalization of $142.37 billion, a price-to-earnings ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a fifty day simple moving average of $193.14 and a 200 day simple moving average of $193.21.
Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the business earned $0.77 EPS. The business's quarterly revenue was up 5.5% compared to the same quarter last year. Sell-side analysts expect that Danaher Corporation will post 8.53 EPS for the current year.
Danaher Company Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
